http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
xiii, 409 pages, 4 unnumbered pages of plates : illustrations (some color) ; 27 cm.
Cancer immunoediting : from immune surveillance to immune escape -- Immunosurveillance : innate and adaptive antitumor immunity -- Cytokine regulation of immune tolerance to tumors -- Immunological sculpting : natural killer cell receptors and ligands -- Immune escape : immunosuppressive networks -- Cytotoxic chemotherapy in clinical treatment of cancer -- Targeted therapeutics in cancer treatment -- Concepts in pharmacology and toxicology -- Cancer immunotherapy : challenges and opportunities -- Cancer vaccines -- Immunotherapy and cancer therapeutics : why partner? -- Immune stimulatory features of classical chemotherapy-- Dendritic cells and coregulatory signals : immune checkpoint blockade to stimulate immunotherapy -- Regulatory T cells in tumor immunity : role of toll-like receptors -- Tumor-associated macrophages in cancer growth and progression -- Tumor-associated myeloid-derived suppressor cells -- Programmed death ligand-1 and galectin-1 : pieces in the puzzle of tumor-immune escape -- Indoleamine 2,3-dioxygenase in immune escape : regulation and therapeutic inhibition -- Arginase, nitric oxide synthase, and novel inhibitors of L-arginine metabolism in immune modulation
edited by George C. Prendergast, Elizabeth M. Jaffee.
Includes bibliographical references and index.